FDA Approves Low-dose Regimen Of Premarin Vaginal Cream To Treat Moderate To Severe Postmenopausal Dyspareunia Painful ... (Medical News Today)
PREMARIN (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal dyspareunia (painful sexual intercourse) announced Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE).

Asthma - ZaBeCor's Investigational New Drug Application Approved By The FDA (Medical News Today)
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announces today that the United States Food and Drug Administration ("FDA") has approved the Company's Investigational New Drug Application ("IND") for the treatment of asthma. This approval enables the Company to proceed with Phase I clinical trials in humans for its asthma drug candidate, Excellair(TM).

TheraQuest's IND For Abuse Deterrent Strong Opioid (TQ-1015) Accepted By FDA (Medical News Today)
TheraQuest Biosciences, Inc. a development stage pain management company announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug ("IND") application for TQ-1015, its abuse deterrent extended release strong opioid. TQ-1015 is being developed using SECUREL(R), TheraQuest's proprietary abuse deterrent technology.